LabCorp Venture Fund
North America, North Carolina, United States, Burlington
Description
LabCorp Venture Fund invests in early stage private companies operating in current or strategically adjacent spaces.
Investor Profile
LabCorp Venture Fund has backed more than 12 startups, with 2 new investments in the last 12 months alone. The firm has led 3 rounds, about 25% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, Denmark.
- Strong thematic focus on Health Care, Biotechnology, Health Diagnostics.
- Led 2 rounds in the past year.
Stage Focus
- Series Unknown (42%)
- Series B (17%)
- Series A (17%)
- Convertible Note (8%)
- Seed (8%)
- Series E (8%)
Country Focus
- United States (83%)
- Switzerland (8%)
- Denmark (8%)
Industry Focus
- Health Care
- Biotechnology
- Health Diagnostics
- Medical
- Clinical Trials
- Product Research
- Medical Device
- Wearables
- Women's
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
